Skip to content
#gene editing Review

"The pharmacological potential of CRISPR-Cas9: Revolutionizing gene therapy and drug development".

Sep 2026 · Nucleosides, Nucleotides & Nucleic Acids · pp. 1-33 · 0 citations · 100 references
Medicine

TL;DR

Further advancements in CRISPR technology such as high-fidelity CRISPR and new systems Cas12 and Cas13 which increases efficiency of editing and opens more opportunities are discussed which increases efficiency of editing and opens more opportunities.

Abstract

CRISPR-Cas9 has entered the mainstream of genetic research and therapeutic development, offering a level of programmable and targeted gene editing that has substantially expanded the possibilities of genetic manipulation. This review focuses on the discovery to development of CRISPR-Cas9 and its recent practice in pharmacological and biotechnology field. We discuss further advancements in CRISPR technology such as high-fidelity CRISPR and new systems Cas12 and Cas13 which increases efficiency of editing and opens more opportunities. CRISPR technology has been further advanced when combined with Artificial Intelligence and Machine Learning; guide RNA is now optimized while the off-target effects are predicted. The review also focuses on the new targets for therapy, recent trials, the legal and the social and ethical relevance of the CRISPR approach. With the development of CRISPR-Cas9 promising and revolutionary preliminary achievements in the fields of drug development and disease management and tissue engineering are anticipated. Although, in its application, there are questions that have been raised concerning side effects, carriers, and ethics, it is important to take advantage of it in the right manner. As seen in this review, CRISPR-Cas9 plays the crucial part of the development of biomedical studies and therapeutic paradigms.

View source

Similar papers

Review Aug 2026

Exploring the Potential of CRISPR-Cas9 in Carcinoma Therapy: Advances, Challenges and Future Perspectives.

The mechanisms of CRISPR-Cas9 gene editing, recent technological advancements, and prospects for cancer management are explored and insights into strategies for precise delivery, improved targeting accuracy, and the regulatory considerations surrounding CRISPR-Cas9 for oncological applications are provided.

Nikhil Rawal, Shruti Batra, Tanu Sharma et al. · 0 citations
#gene editing Review Sep 2026

CRISPR–cas systems in pharmacology: functional pharmacogenomics, drug screening, resistance, and therapeutic translation

Overall, CRISPR-Cas9 represents a vital platform for future pharmacological innovation, but its broad clinical use may require further validation of safety, efficacy, durability, and accessibility.

Muhammad Saeed Akhtar, Adnan Amin · 0 citations
Review Dec 2024

Journal of Population Therapeutics & Clinical Pharmacology

This review starts by examining the advantages and limitations of various physical methods for delivering Cas9, and highlights key applications of CRISPR systems in epigenetic modifications, and explores the use of CRISPR-Cas9 technology in genome editing, with a particular focus on base editing and prime editing.

Suhail Ahmad Sheikh, W. Shah, Azka Khan et al. · 0 citations
Review Sep 2026

Artificial Intelligence Integration into Gene Editing: Prospects, Challenges and Therapeutic Applications: Review Article

In gene editing, CRISPR-Cas9 has revolutionized the field and led to advancements such as base editing and prime editing. This decade's most significant advancement was the creative convergence of these technologies with artificial intelligence (AI) techniques, particularly deep learning and large language models. The...

Hussein R. Mahmood · 0 citations
#gene editing Open access Sep 2026

CRISPR-Based Gene Editing in Human and Animal Health: Revolutionizing Disease Resistance and Treatment

This study explores the diverse applications of CRISPR, highlighting its role in treating genetic disorders such as sickle cell anemia and Duchenne muscular dystrophy, advancing cancer immunotherapies, and developing CRISPR-based antiviral therapies for HIV and COVID-19.

B. Aloufi · 0 citations

Related blog posts

Microsoft Research Blog Nov 12, 2026

Microsoft Research Focus – Edition #98

What's new in research at Microsoft? Host Anson Ho explores the latest, including AI-powered universal translation, a breakthrough in a 31-year-old mathematics challenge, and advances making AI coding agents faster and more efficient.  The post Microsoft Research Focus – Edition #98 appeared first on Microsoft Research.

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.